TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2014

Randomized, phase III trial of first-line figitumumab in combination with paclitaxel and carboplatin versus paclitaxel and carboplatin alone in patients with advanced non-small-cell lung cancer.

Corey J Langer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.